Grenada

Reimbursed Care Access

Grenada operates a prohibitionist, control-focused drug policy under the Drug Abuse (Prevention and Control) Act (CAP 84A). Conventional medical use of ketamine as an anaesthetic is practiced in clinical settings (consistent with WHO essential medicines guidance), but serotonergic psychedelics and other novel compounds have no authorized medical framework or reimbursement pathway outside of tightly controlled research — and Grenadian legislation makes no specific provision for medical cannabis or analogous psychotropic research. [https://fase2.copolad.eu/en/entrevista/Grenada|COPOLAD: Grenada Drug Control Secretariat][https://www.who.int/groups/expert-committee-on-selection-and-use-of-essential-medicines/essential-medicines-lists|WHO Model Lists of Essential Medicines]